LENZ vs PSA · rev $19.1M vs rev $4.82B
LENZ Therapeutics Inc (LENZ) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
PSA (PSA) common stock.
Latest reported LENZ revenue for 2025-12-31 was $19.1M. Net income was -$82.1M. LENZ currently screens at market cap $223.6M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
LENZ currently screens at market cap $223.6M. PSA currently screens at market cap $0.
Not investment advice. Open the LENZ and PSA stock pages for the full models.
Not investment advice.